RTRachel A. Taylor

Rachel A. Taylor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rachel A. Taylor has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Risk from Reopening International Travel During a Disease X Pandemic: A Case Study of SARS‐CoV‐2

    by Rachel A. Taylor, Catherine McCarthy, Virag Patel, Kai T. F. Man, Ruth Moir, Louise A. Kelly, Emma L. Snary

    During the COVID‐19 pandemic, caused by SARS‐CoV‐2, many mathematical models and risk assessments have been created to inform policymakers on effective strategies for controlling the spread of the pathogen. These models were often developed rapidly for timely input to strategic decisions. It is prudent to evaluate the models created and learn from experience so that we can be adequately prepared for a future pandemic. One area of modeling developed during the COVID‐19 pandemic was for international travel and how to safely reopen borders and to which countries. We developed an importation risk model for estimating the risk of SARS‐CoV‐2 infectious travelers entering any airport and parameterized it for UK airports. We ran the model using prevalence estimates from August 2020 and found that 895 (CI: 834–958) infectious travelers would arrive in a single week from the 25 countries considered. We simulated health measures on arrival to assess the efficacy of self‐isolation, the policy at the time, in comparison to proposed alternatives. We found that the 14‐day self‐isolation is 78.0% effective (CI: 74.4–81.6), whereas a test at the airport plus an additional test 4 days later is 68.9% (CI: 64.9–73.0) effective, after accounting for 20% noncompliance. Rapidly implementing control measures for travelers from riskier countries is vital to protect public health. This methodology can be quickly updated to assess the impact of any further changes to international travel policy or disease occurrence. We assess whether our model results would be applicable for a future Disease X, the adaptability of our model, future work to ensure that the model is comprehensive, and the lessons learned from modeling during COVID‐19. In particular, we highlight the importance of building flexible, transparent, and adaptable models due to the speed at which policy or the epidemiological situation can change and for use in any future pandemic.

  • Open Access

    West Nile Virus spread in Europe - phylogeographic pattern analysis and key drivers

    by Lu Lu, Feifei Zhang, Bas B. Oude Munnink, Emmanuelle Munger, Reina S. Sikkema, Styliani Pappa, Katerina Tsioka, Alessandro Sinigaglia, Emanuela Dal Molin, Barbara B. Shih, et al.

    Spread and emergence of West Nile virus (WNV) in Europe have been very different from those observed in North America. Here, we describe key drivers by combining viral genome sequences with epidemiological data and possible factors of spread into phylodynamic models. WNV in Europe has greater lineage diversity than other regions of the world, suggesting repeated introductions and local amplification. Among the six lineages found in Europe, WNV-2a is predominant, has spread to at least 14 countries and evolved into two major co-circulating clusters (A and B). Both of these seem to originate from regions of Central Europe. Viruses of Cluster A emerged earlier and have spread towards the west of Europe with higher genetic diversity. Amongst multiple drivers, high agriculture activities were associated with both spread direction and velocity. Our study suggests future surveillance activities should be strengthened in Central Europe and Southeast European countries, and enhanced monitoring should be targeted to areas with high agriculture activities.


  • Open Access

    Interventions to prevent hypothermia in extremely preterm low-weight infants undergoing cardiac catheterisation

    by Eliane Alhalabi, Maria Zestos, Daisuke Kobayashi, George M Mckelvey, Rachel A Taylor

    Background In January 2019, a new device called the Amplatzer Piccolo Occluder was approved by the US Food and Drug Administration for percutaneous closure of patent ductus arteriosus in infants weighing more than 700 g and of postnatal age more than 3 days. Premature low-weight infants are predisposed to hypothermia when transported outside of the thermo-neutral environment. At our institution, 90% of extremely preterm low-weight infants developed transient moderate hypothermia in the cardiac catheterisation suite. Methods We conducted a study testing multiple hypotheses aimed at preventing hypothermia in the cardiac catheterisation suite. Interventions included increasing ambient room temperature, reducing exposure to cold environment and reducing overall time spent in the remote location. The primary outcome was the proportion of patients who developed transient hypothermia at the start of the procedure in the cardiac catheterisation suite. The secondary measures included mean core body temperature at four different instances, as well as anaesthesia time, procedure time and radiation exposure. Results During the study period, 10 patients were enrolled in each group. The postintervention group saw a reduction in transient hypothermia from 90% to 40% (absolute risk reduction 50%, p=0.02). Data analysis showed an improvement in mean core body temperature (35.4°C vs 36.4°C, pConclusion The application of the interventions reduced hypothermia in this high-risk population. The implementation of a protocol with collaboration of a multidisciplinary team is indispensable in providing optimal care to extremely preterm infants.


  • Open Access

    Modelling the temperature suitability for the risk of West Nile Virus establishment in European Culex pipiens populations

    by Gabriella Di Pol, Matteo Crotta, Rachel A. Taylor

    Increases in temperature and extreme weather events due to global warming can create an environment that is beneficial to mosquito populations, changing and possibly increasing the suitable geographical range for many vector‐borne diseases. West Nile Virus (WNV) is a flavivirus, maintained in a mosquito–avian host cycle that is usually asymptomatic but can cause primarily flu‐like symptoms in human and equid accidental hosts. In rare circumstances, serious disease and death are possible outcomes for both humans and horses. The main European vector of WNV is the Culex pipiens mosquito. This study examines the effect of environmental temperature on WNV establishment in Europe via Culex pipiens populations through use of a basic reproduction number (R0) model. A metric of thermal suitability derived from R0 was developed by collating thermal responses of different Culex pipiens traits and combining them through use of a next‐generation matrix. WNV establishment was determined to be possible between 14°C and 34.3°C, with the optimal temperature at 23.7°C. The suitability measure was plotted against monthly average temperatures in 2020 and the number of months with high suitability mapped across Europe. The average number of suitable months for each year from 2013 to 2019 was also calculated and validated with reported equine West Nile fever cases from 2013 to 2019. The widespread thermal suitability for WNV establishment highlights the importance of European surveillance for this disease and the need for increased research into mosquito and bird distribution.


  • Open Access

    Microbial risk assessment of Escherichia coli shiga-toxin producers (STEC) in raw sheep's milk cheeses in Italy

    by Roberto Condoleo, Roberta Palumbo, Ziad Mezher, Luca Bucchini, Rachel A. Taylor


  • Open Access

    The risk of introducing SARS-CoV-2 to the UK via international travel in August 2020

    by Rachel A. Taylor, Catherine McCarthy, Virag Patel, Ruth Moir, Louise A Kelly, Emma L Snary

    International travel poses substantial risks for continued introduction of SARS-CoV-2. As of the 17 th August 2020, travellers from 12 of the top 25 countries flying into the UK are required to self-isolate for 14 days. We estimate that 895 (CI: 834–958) infectious travellers arrive in a single week, of which 87% (779, CI: 722–837) originate from countries on the UK quarantine list. We compare alternative measures to the 14 day self-isolation (78.0% effective CI: 74.4–81.6) which could be more feasible long-term. A single RT-PCR taken upon arrival at the airport is 39.6% (CI: 35.2–43.7) effective, or equivalently, it would only detect 2 in 5 infectious passengers. Alternatively, testing four days after arrival is 64.3% (CI: 60.0–68.3) effective whereas a test at the airport plus additional test four days later is 68.9% (CI: 64.9–73.0) effective. Rapidly implementing control measures for travellers from risky countries is vital to protect public health; this methodology can be quickly updated to assess the impact of any further changes to international travel policy or disease occurrence.


  • Open Access

    An improved methodology for estimating the prevalence of SARS-CoV-2

    by Virag Patel, Catherine McCarthy, Rachel A Taylor, Ruth Moir, Louise A Kelly, Emma L Snary

    Since the identification of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019, there have been more than 17 million cases of the disease in 216 countries worldwide. Comparisons of prevalence estimates between different communities can inform policy decisions regarding safe travel between countries, help to assess when to implement (or remove) disease control measures and identify the risk of over-burdening healthcare providers. Estimating the true prevalence can, however, be challenging because officially reported figures are likely to be significant underestimates of the true burden of COVID-19 within a community. Previous methods for estimating the prevalence fail to incorporate differences between populations (such as younger populations having higher rates of asymptomatic cases) and so comparisons between, for example, countries, can be misleading. Here, we present an improved methodology for estimating COVID-19 prevalence. We take the reported number of cases and deaths (together with population size) as raw prevalence for the population. We then apply an age-adjustment to this which allows the age-distribution of that population to influence the case-fatality rate and the proportion of asymptomatic cases. Finally, we calculate the likely underreporting factor for the population and use this to adjust our prevalence estimate further. We use our method to estimate the prevalence for 166 countries (or the states of the United States of America, hereafter referred to as US state) where sufficient data were available. Our estimates show that as of the 30 th July 2020, the top three countries with the highest estimated prevalence are Brazil (1.26%, 95% CI: 0.96 – 1.37), Kyrgyzstan (1.10%, 95% CI: 0.82 – 1.19) and Suriname (0.58%, 95% CI: 0.44 – 0.63). Brazil is predicted to have the largest proportion of all the current global cases (30.41%, 95%CI: 27.52 – 30.84), followed by the USA (14.52%, 95%CI: 14.26 – 16.34) and India (11.23%, 95%CI: 11.11 – 11.24). Amongst the US states, the highest prevalence is predicted to be in Louisiana (1.07%, 95% CI: 1.02 – 1.12), Florida (0.90%, 95% CI: 0.86 – 0.94) and Mississippi (0.77%, 95% CI: 0.74 – 0.81) whereas amongst European countries, the highest prevalence is predicted to be in Montenegro (0.47%, 95% CI: 0.42 - 0.50), Kosovo (0.35%, 95% CI: 0.29 - 0.37) and Moldova (0.28%, 95% CI: 0.23 - 0.30). Our results suggest that Kyrgyzstan (0.04 tests per predicted case), Brazil (0.04 tests per predicted case) and Suriname (0.29 tests per predicted case) have the highest underreporting out of the countries in the top 25 prevalence. In comparison, Israel (34.19 tests per predicted case), Bahrain (19.82 per predicted case) and Palestine (9.81 tests per predicted case) have the least underreporting. The results of this study may be used to understand the risk between different geographical areas and highlight regions where the prevalence of COVID-19 is increasing most rapidly. The method described is quick and easy to implement. Prevalence estimates should be updated on a regular basis to allow for rapid fluctuations in disease patterns.


  • Predicting spread and effective control measures for African swine fever—Should we blame the boars?

    by Rachel A. Taylor, Tomasz Podgórski, Robin R. L. Simons, Sophie Ip, Paul Gale, Louise A. Kelly, Emma L. Snary

    An ongoing, continually spreading, outbreak of African swine fever (ASF), following its identification in Georgia in 2007, has resulted in 17 European and 12 Asian countries reporting cases by April 2020, with cases occurring in both wild boar and domestic pigs. Curtailing further spread of ASF requires understanding of the transmission pathways of the disease. ASF is self-sustaining in the wild boar population and they have been implicated as one of the main drivers of transmission within Europe. We developed a spatially-explicit model to estimate the risk of infection with ASF in wild boar and pigs due to natural movement of wild boar that is applicable across the whole of Europe. We demonstrate the model by using it to predict the probability that early cases of ASF in Poland were caused by wild boar dispersion. The risk of infection in 2015 is computed due to wild boar cases in Poland in 2014, compared against reported cases in 2015 and then the procedure is repeated for 2015-2016. We find that long- and medium-distance spread of ASF (i.e. >30km) is unlikely to have occurred due to wild boar dispersal, due in part to the generally short distances wild boar will travel (<20km on average). We also predict the relative success of different control strategies in 2015, if they were implemented in 2014. Results suggest that hunting of wild boar reduces the number of new cases, but a larger region is at risk of ASF compared to no control measure. Alternatively, introducing wild boar-proof fencing reduces the size of the region at risk in 2015, but not the total number of cases. Overall, our model suggests wild boar movement is only responsible for local transmission of disease, thus other pathways are more dominant in medium and long distance spread of the disease.


  • Open Access

    The Risk of Infection by African Swine Fever Virus in European Swine Through Boar Movement and Legal Trade of Pigs and Pig Meat

    by Rachel A. Taylor, Roberto Condoleo, Robin R. L. Simons, Paul Gale, Louise A. Kelly, Emma L. Snary

    African swine fever (ASF) is currently spreading westwards throughout Europe and eastwards into China, with cases occurring in both wild boar and domestic pigs. A generic risk assessment framework is used to determine the probability of first infection with ASF virus (ASFV) at a fine spatial scale across European Union Member States. The framework aims to assist risk managers across Europe with their ASF surveillance and intervention activities. Performing the risk assessment at a fine spatial scale allows for hot-spot surveillance, which can aid risk managers by directing surveillance or intervention resources at those areas or pathways deemed most at risk, and hence enables prioritization of limited resources. We use 2018 cases of ASF to estimate prevalence of the disease in both wild boar and pig populations and compute the risk of initial infection for 2019 at a 100 km2 cell resolution via three potential pathways: legal trade in live pigs, natural movement of wild boar, and legal trade in pig meat products. We consider the number of pigs, boar and amount of pig meat entering our area of interest, the prevalence of the disease in the origin country, the probability of exposure of susceptible pigs or boar in the area of interest to introduced infected pigs, boar, or meat from an infected pig, and the probability of transmission to susceptible animals. We provide maps across Europe indicating regions at highest risk of initial infection. Results indicate that the risk of ASF in 2019 was predominantly focused on those regions which already had numerous cases in 2018 (Poland, Lithuania, Hungary, Romania, and Latvia). The riskiest pathway for ASFV transmission to pigs was the movement of wild boar for Eastern European countries and legal trade of pigs for Western European countries. New infections are more likely to occur in wild boar rather than pigs, for both the pig meat and wild boar movement pathways. Our results provide an opportunity to focus surveillance activities and thus increase our ability to detect ASF introductions earlier, a necessary requirement if we are to successfully control the spread of this devastating disease for the pig industry.


  • Evaluating a mixed abiotic–biotic model for the distribution and host contact rates of an arthropod vector of pathogens: An example with Ixodes ricinus (Ixodidae)

    by Agustín Estrada-Peña, Amie Adkin, Silvia Bertolini, Charlotte Cook, Maria Ines Crescio, Vladimir Grosbois, Verity Horigan, Sophie Ip, Anaïs Leger, Gianluca Mastrantonio, et al.